Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
Australian Market
Holding AU:BGT?
Track your performance easily

Bio-Gene Technology Ltd. (BGT) Financial Statements

4 Followers

Bio-Gene Technology Ltd. Financial Overview

Bio-Gene Technology Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.014; its P/E ratio is -3.72; Bio-Gene Technology Ltd. is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19
Income Statement-
Total Revenue----
Gross Profit----
EBIT----
EBITDA----
Net Income Common Stockholders----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 6.34MAU$ 3.93MAU$ 5.52MAU$ 4.50M
Total AssetsAU$ 7.30MAU$ 5.00MAU$ 6.57MAU$ 5.56M
Total DebtAU$ 0.00AU$ 0.00AU$ 11.66KAU$ 0.00
Net DebtAU$ -6.34MAU$ -3.93MAU$ -5.51MAU$ -4.50M
Total LiabilitiesAU$ 1.03MAU$ 754.57KAU$ 567.29KAU$ 613.61K
Stockholders EquityAU$ 6.27MAU$ 4.25MAU$ 6.00MAU$ 4.95M
Cash Flow-
Free Cash Flow----
Operating Cash Flow----
Investing Cash Flow----
Financing Cash Flow----
Currency in AUD

Bio-Gene Technology Ltd. Earnings and Revenue History

Bio-Gene Technology Ltd. Debt to Assets

Bio-Gene Technology Ltd. Cash Flow

Bio-Gene Technology Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis